Chiara Casadei
Overview
Explore the profile of Chiara Casadei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
549
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farolfi A, Montanari D, Casadei C, Musolino A
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002940
For years, treatment options for advanced gynecological malignancies have been limited, with the combination of carboplatin and paclitaxel being the preferred first-line therapeutic approach, regardless of disease type [...].
2.
Merloni F, Palleschi M, Gianni C, Sirico M, Serra R, Casadei C, et al.
Clin Exp Metastasis
. 2024 Sep;
41(6):863-875.
PMID: 39312051
Metastatic breast cancer (MBC) is still an incurable disease, which eventually develops resistance mechanisms against systemic therapies. While most patients experience widespread disease progression during systemic treatment (ST), in some...
3.
Giunta E, Caroli P, Scarpi E, Altavilla A, Rossetti V, Marini I, et al.
Eur J Nucl Med Mol Imaging
. 2024 Aug;
52(1):326-334.
PMID: 39207484
Purpose: to assess the utility of response monitoring to enzalutamide by using [Ga]Ga-PSMA PET in mCRPC patients treated with enzalutamide as first-line therapy. Methods: patients underwent [Ga]Ga-PSMA PET less than...
4.
Casadei C, Scarpi E, Conteduca V, Gurioli G, Cursano M, Brighi N, et al.
Eur Urol Open Sci
. 2024 Feb;
61:44-51.
PMID: 38384439
Background: The prevalence of pathogenic germline mutations in DNA damage repair (gDDR) genes in the Italian population is unknown. Objective: In this prospective multicenter cohort study, we evaluated the prevalence...
5.
Faria S, Giannarelli D, Cordeiro de Lima V, Anwar S, Casadei C, De Giorgi U, et al.
Oncologist
. 2023 Nov;
29(4):e447-e454.
PMID: 37971409
Background: Breast cancer-related inflammation is critical in tumorigenesis, cancer progression, and patient prognosis. Several inflammatory markers derived from peripheral blood cells count, such as the neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio...
6.
Anpalakhan S, Signori A, Cortellini A, Verzoni E, Giusti R, Aprile G, et al.
iScience
. 2023 Oct;
26(11):107970.
PMID: 37860695
The neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammatory index (SII) have been reported as prognosticators in non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), and melanoma. This analysis of the...
7.
Cursano M, Giunta E, Scarpi E, Casadei C, Virga A, Ulivi P, et al.
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569810
Up to 80% of castration-resistant prostate cancer (CRPC) patients develop bone metastases during the natural history of disease and about 25% harbor mutations in DNA damage repair (DDR) genes. This...
8.
Bersanelli M, Verzoni E, Cortellini A, Giusti R, Calvetti L, Ermacora P, et al.
EClinicalMedicine
. 2023 Jul;
61:102044.
PMID: 37434748
Background: The prospective multicentre observational INVIDIa-2 study investigated the clinical effectiveness of influenza vaccination in patients with advanced cancer receiving immune checkpoint inhibitors (ICI). In this secondary analysis of the...
9.
Merloni F, Palleschi M, Casadei C, Romeo A, Curcio A, Casadei R, et al.
Ther Adv Med Oncol
. 2023 Mar;
15:17588359231161412.
PMID: 36950272
Metastatic breast cancer (BC) is considered an incurable disease and is usually treated with palliative intent. However, about 50% of metastatic BCs present with only a few metastatic lesions and...
10.
Schepisi G, Gianni C, Palleschi M, Bleve S, Casadei C, Lolli C, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900394
Breast cancer represents one of the most common tumor histologies. To date, based on the specific histotype, different therapeutic strategies, including immunotherapies, capable of prolonging survival are used. More recently,...